drug
capecitabine
Marketedupdated 3mo agoby Armas Pharmaceuticals Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 7- tagApproval72 co-mentions · 36 sources
- tagSmall Molecule36 co-mentions · 36 sources
- tagOncology7 co-mentions · 3 sources
- tagColorectal Cancer2 co-mentions · 2 sources
- companyJapanese Governmental Office1 co-mentions · 1 sources
- companySun Yat-sen Memorial Hospital1 co-mentions · 1 sources
- companyCancer Institute and Hospital Chinese Academy of Medical Sciences1 co-mentions · 1 sources
indications
investigational
Colorectal Cancer
all catalysts(3)
phase 2 completion · 2
Trials studying capecitabine
- phase2A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
- phase3A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- phase3Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- phase3A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- phase1A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
- phase3A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- phase2A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer
- phase1Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
News(1)
- Processa acquires Vidya for potential BTK inhibitor rival to Novartis’ RhapsidoProcessa Pharmaceuticals has made a push into the autoimmune space via the acquisition of Vidya Therapeutics, which delivers a potential rival to Novartis’ Rhapsido.fiercebiotech · 19d ago
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that